Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs
Published in: Drugs 1/2012

01-01-2012 | Review Article

Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung Cancer

Authors: Raffaele Califano, Lorenza Landi, Dr Federico Cappuzzo

Published in: Drugs | Special Issue 1/2012

Login to get access
Metadata
Title
Prognostic and Predictive Value of K-RAS Mutations in Non-Small Cell Lung Cancer
Authors
Raffaele Califano
Lorenza Landi
Dr Federico Cappuzzo
Publication date
01-01-2012
Publisher
Springer International Publishing
Published in
Drugs / Issue Special Issue 1/2012
Print ISSN: 0012-6667
Electronic ISSN: 1179-1950
DOI
https://doi.org/10.2165/1163012-S0-000000000-00000

Other articles of this Special Issue 1/2012

Drugs 1/2012 Go to the issue

EditorialNotes

Foreword

Review Article

Clinical Outcomes with Erlotinib in Patients with Epidermal Growth Factor Receptor Mutation

Review Article

Management of Non-Small Cell Lung in Cancer Patients with Stable Disease

Review Article

Emerging New Agents for the Management of Patients with Non-Small Cell Lung Cancer

Review Article

Role of Erlotinib in the Treatment of Non-Small Cell Lung Cancer